HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

p-methoxy-diphenyl diselenide

a neuroprotective and antinociceptive antioxidant; structure in first source

Also Known As:

(meOPhSe)2; 4,4'-methoxyldiphenyl diselenide; p,p'-methoxyldiphenyl diselenide

Networked: 8 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        p-methoxy-diphenyl diselenide: 8
- Organoselenium Compounds: 63
  - p-methoxy-diphenyl diselenide: 8

Experts

1.	Nogueira, Cristina Wayne: 5 articles (11/2016 - 03/2010)
2.	Pinton, Simone: 5 articles (06/2013 - 03/2010)
3.	Zeni, Gilson: 2 articles (11/2016 - 03/2010)
4.	Ramalho, Rita M: 2 articles (06/2013 - 01/2013)
5.	Rodrigues, Cecília M P: 2 articles (06/2013 - 01/2013)
6.	Prigol, Marina: 2 articles (01/2013 - 04/2011)
7.	da Rocha, Juliana Trevisan: 2 articles (04/2011 - 03/2010)
8.	Alberto-Silva, Carlos: 1 article (09/2022)
9.	Costa, Maricilia Silva: 1 article (09/2022)
10.	Passos, Juliene Cristina da Silva: 1 article (09/2022)

Related Diseases

1.	Dementia (Dementias) 01/01/2013 - "Thus, the aim of the current study was to investigate the therapeutic effect of p,p'-methoxyl-diphenyl diselenide [(MeOPhSe)(2)], an organoselenium compound, against streptozotocin (STZ)-induced sporadic dementia of Alzheimer's type (SDAT) in rats. " 01/01/2013 - "The purpose of this study was to investigate possible molecular targets involved in the neuroprotective effect of p,p'-methoxyl-diphenyl diselenide [(MeOPhSe)2], using a streptozotocin (STZ)-induced sporadic dementia of Alzheimer's type rat model. " 03/12/2010 - "The present study was designed to investigate the possible neuroprotective effect of p,p'-methoxyl-diphenyl diselenide [(MeOPhSe)(2)] in a model of sporadic dementia of Alzheimer's type (SDAT) induced by intracerebroventricular (i.c.v.) injection of streptozotocin (STZ) in mice. " 04/01/2011 - "The present study investigated whether the antioxidant activity of p,p'-methoxyl-diphenyl diselenide [(MeOPhSe)(2)] is involved in its protective effect against cognitive impairment induced by streptozotocin (STZ) in a model of sporadic dementia of Alzheimer's type (SDAT). "
2.	Cognitive Dysfunction 04/01/2011 - "The present study investigated whether the antioxidant activity of p,p'-methoxyl-diphenyl diselenide [(MeOPhSe)(2)] is involved in its protective effect against cognitive impairment induced by streptozotocin (STZ) in a model of sporadic dementia of Alzheimer's type (SDAT). "
3.	Mitochondrial Diseases (Mitochondrial Disease) 11/01/2011 - "We evaluated the potential neuroprotective effect of 1-100 µM of four organoselenium compounds: diphenyl diselenide, 3'3-ditri-fluoromethyldiphenyl diselenide, p-methoxy-diphenyl diselenide, and p-chloro-diphenyl diselenide, against methylmercury-induced mitochondrial dysfunction and oxidative stress in mitochondrial-enriched fractions from adult Swiss mouse brain. "
4.	Pain (Aches) 11/15/2016 - "Pain-depression dyad was induced by daily subcutaneous reserpine injection (0.5mg/kg for three consecutive days) from 22 to 24 day of (MeOPhSe)2 supplementation. "
5.	Memory Disorders (Memory Loss) 06/15/2013 - "Furthermore, the therapeutic effect of (MeOPhSe)2 (5 mg/kg, oral route, daily for 5 days) on memory deficits was evaluated in mice exposed to Aβ fragment 25-35 (3 nmol/3 μl/per site, intracerebroventricular infusion). "

Related Drugs and Biologics

1.	Streptozocin (Streptozotocin)
2.	p,p'-methoxyl-diphenyl diselenide
3.	Neuroprotective Agents
4.	Therapeutic Uses
5.	Antioxidants
6.	Organoselenium Compounds
7.	Reserpine (Serpasil)
8.	p-chloro-diphenyl diselenide
9.	diphenyldiselenide

Related Therapies and Procedures

1.	Intraventricular Infusions